relx plc (REL:London)
David R. Brennan
Former Non-Executive Director, RELX Group plc
|Age||Total Calculated Compensation||This person is connected to 22 board members in 3 different organizations across 9 different industries.|
See Board Relationships
Mr. David R. Brennan serves as a Member of Executive Board at Pharmaceutical Research and Manufacturers of America. Mr. Brennan served as the Chief Executive Officer of AstraZeneca Plc at MedImmune, LLC from January 1, 2006 to June 1, 2012. Mr. Brennan served as Treasurer of the Pharmaceutical Research and Manufacturers of America since March 2007. He served as the President and Chief Executive Officer of AstraZeneca Pharmaceuticals LP (which does business as Astrazeneca ...
1-3 StrandPhone: 44 20 7166 5500
London, Greater London WC2N 5JR
Fax: 44 20 7166 5799
Board Members Memberships*
Director and Member of Compensation Committee
Director, Member of Pharmaceutical Compliance & Quality Committee and Member of Strategy & Risk Committee
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|George A. Scangos Ph.D.||Chief Executive Officer and Director|
|Miles D. White||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|John C. Lechleiter Ph.D.||Chairman, Chief Executive Officer and President|
Eli Lilly and Company
|Inge G. Thulin||Chairman, Chief Executive Officer and President|
|J. Michael Pearson||Chairman and Chief Executive Officer|
Valeant Pharmaceuticals International, Inc.
|$1.9M||Compensation as of Fiscal Year 2014.|